Phone
Address Talkabouturology, Nizhny Novgorod, Russia
Skype ukitcom
Email Talkabouturology@list.ru
                                    Talk about urology

Back to the list

Patients with poor prognosis, metastatic castration-resistant #prostatecancer might benefit slightly more from cabazitaxel than from androgen-receptor pathway inhibitors.Find out more in the UROONCO PCa Article of the Month with expert commentary

https://prostate.uroonco.uroweb.org/publication/cabazitaxel-vs-abiraterone-or-enzalutamide-poor-prognosis-mcrpc-multicentre-randomised-open-label-phase-2-trial/